← Back to Search

OCM-RISE Implementation for Opioid Use Disorder

N/A

Waitlist Available

Led By Edward Nunes, MD

Research Sponsored by New York State Psychiatric Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 30 months

Awards & highlights

Study Summary

This trial is designed to study how to best implement a new court model - the opioid court model - across New York State in order to reduce overdose, opioid use disorder, and recidivism.

Who is the study for?

This trial is for adults over the age of 18 who are employed at substance use treatment agencies or by the Unified Court System/County Court in participating counties. Participants must understand and speak English. There are no specific exclusion criteria listed, meaning a wide range of individuals involved in these systems may participate.Check my eligibility

What is being tested?

The OCM-RISE intervention is being tested to improve the opioid court model (OCM) across New York State. The goal is to address opioid use disorder (OUD), reduce overdoses, and lower recidivism by refining rapid screening processes and linking individuals to medication-assisted treatments more effectively.See study design

What are the potential side effects?

Since this trial focuses on implementing a system-level intervention rather than testing a medical drug, it does not have traditional side effects. However, there could be indirect impacts on staff workload or resource allocation within participating institutions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 30 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 30 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 30 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who are abstinent from opioid use

Number of participants who are retained in treatment for at least 60 days

Number of participants who graduate from court

+1 more

Secondary outcome measures

Acceptability of the opioid court

Adoption of OCM RISE

Number of court participants who are provided medication for Opioid Use Disorder (MOUD) Initiation

+3 more

Other outcome measures

Defendant Characteristics

Inter-agency Organizational Features

Knowledge, Attitudes towards MOUD

+7 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: OCM-RISEExperimental Treatment1 Intervention

Opioid court team provided external facilitation to generate action plans to develop and roll out or improve practice of the county opioid court.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Drug AbuseFED

9 Previous Clinical Trials

11,079 Total Patients Enrolled

New York State Psychiatric InstituteLead Sponsor

475 Previous Clinical Trials

150,467 Total Patients Enrolled

Center for Court InnovationOTHER

2 Previous Clinical Trials

613 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the major goals of this scientific investigation?

"This clinical trial's primary objective is to assess the number of opioid abstinent participants over a mean period of 30 months. The secondary endpoints encompass UCMS data field, feedback from an interagency change team focus group regarding OCM RISE acceptability and continued screening/treatment enrollment past 12 months post-implementation phase cessation for MOUD initiation sustainability."

Answered by AI

What is the cumulative enrollment rate for this research study?

"Indeed, the clinicaltrial.gov database illustrates that this research endeavour is currently seeking participants. This trial was first made available to the public on March 18th 2020 and recently edited on November 1st 2022; it seeks 3440 patients from a singular site."

Answered by AI

Is it possible to enlist in this clinical research endeavor at present?

"Clinicaltrials.gov confirms that this medical trial is still seeking participants, having been posted on March 18th 2020 and recently revised November 1st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Facilitating Opioid Care Connections

Katherine Elkington 2020. "Facilitating Opioid Care Connections". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04216719.

All > Opioid Dependence